Australia receives first batch of AstraZeneca vaccines

Marco Green
Февраля 28, 2021

Australia has received its first overseas shipment of the Oxford-AstraZeneca COVID-19 vaccine as it looks to ramp up its national vaccination program.

The federal government says it hopes the new vaccine will be going into people's arms from Monday, March 8.

The vaccine manufacturer said it would only be able to deliver half the COVID-19 vaccines it was contracted to supply the European Union in the second quarter, an European Union representative told Reuters.

"All of the safety protocols are strong and that first shipment of AstraZeneca has now arrived in Australia".

Australians have been getting vaccinated for the last week.

A month ago, the commission said it was recommending the use of the Oxford-AstraZeneca vaccine only for under-65-year-olds due to insufficient data on its effectiveness on older people.

That vaccine needs to be transported and stored in ultra-cold temperatures.

After muddled communication about the efficacy of the British-made jabs hit demand, doctors and public health officials have pleaded with Germans to take up AstraZeneca vaccines.

This vaccine is manufactured offshore and requires two doses, each administered 21 days apart.

First shipment of AstraZeneca vaccine lands in Australia
Australia receives first batch of AstraZeneca vaccines

Australia has secured more than 50 million doses of the vaccine.

The government's initial advertising campaign launched in January focused on informing the Australian community about the Therapeutic Goods Administration's world-leading independent approval process.

"We will now be able to scale up the vaccination rollout to our priority groups, including our most vulnerable Australians and to our frontline border and health workers", Prime Minister Scott Morrison said.

"Australians have put their shoulders to the cause", Mr Hunt said about the people who got vaccinated.

The AstraZeneca vaccine is now being offered in France to people 5- to-64-years-old with health risks, and to health workers under the age of 65.

"Australia is in a unique position because, importantly, this vaccine gives us the ability to manufacture onshore".

Up to four million Australians are expected to be inoculated by March, with Mr Morrison being among a small group receiving the first round of the Pfizer-BioNTech vaccine.

It also found that vaccination was associated with an 81 per cent reduction in hospitalisation risk in the fourth week among those aged 80 years and over, when the results for both vaccines were combined.

Space to play or pause, M to mute, left and right arrows to seek, up and down arrows for volume.

Other reports by

Discuss This Article